Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Shoemark (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), A. Giam (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom). Inflammatory molecular endotypes in bronchiectasis. 2170

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory phenotypes of COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Source: Eur Respir J 2008; 31: 396-406 Year: 2008 Inflammatory markers can predict pulmonary exacerbations of cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Inflammatory cell phenotypes in bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005 Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Inflammatory gene polymorphisms in asthma and chronic obstructive pulmonary disease in Venezuela Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Non-invasive evaluation of airway inflammation in non-CF bronchiectasis Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Macrophage derived inflammatory mediators and thoracic HRCT scoring in scleroderma fibrosing alveolitis Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002 Investigations of broncho-alveolar lavage in children with asthma, bronchiectasis and cystic fibrosis Source: International Congress 2015 – Paediatric bronchology Year: 2015 Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Bronchiectasis associated with inflammatory bowel disease Source: Eur Respir Mon 2011; 52: 163-177 Year: 2011 Chronic rhinosinusitis: from endotyping to biologicals Source: International Congress 2019 – Respiratory medicine meets ear, nose and throat experts Year: 2019